FI952677A - Förfarande för framställning av väsentligen rena enantiomerer av fenylpropionsyra - Google Patents

Förfarande för framställning av väsentligen rena enantiomerer av fenylpropionsyra Download PDF

Info

Publication number
FI952677A
FI952677A FI952677A FI952677A FI952677A FI 952677 A FI952677 A FI 952677A FI 952677 A FI952677 A FI 952677A FI 952677 A FI952677 A FI 952677A FI 952677 A FI952677 A FI 952677A
Authority
FI
Finland
Prior art keywords
pct
phenylpropionic acid
stage
preparation
date jun
Prior art date
Application number
FI952677A
Other languages
English (en)
Finnish (fi)
Other versions
FI110776B (sv
FI952677A0 (sv
Inventor
Robert Hardy
Paul Frederick Coe
Adrian Hirst
Hugh Owen O'donnell
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225202A external-priority patent/GB9225202D0/en
Priority claimed from GB929225203A external-priority patent/GB9225203D0/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of FI952677A0 publication Critical patent/FI952677A0/sv
Publication of FI952677A publication Critical patent/FI952677A/sv
Application granted granted Critical
Publication of FI110776B publication Critical patent/FI110776B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/487—Separation; Purification; Stabilisation; Use of additives by treatment giving rise to chemical modification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI952677A 1992-12-02 1995-06-01 Förfarande för framställning av väsentligen rena enantiomerer av substituerade fenylpropionsyror FI110776B (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB9225203 1992-12-02
GB929225202A GB9225202D0 (en) 1992-12-02 1992-12-02 Process
GB9225202 1992-12-02
GB929225203A GB9225203D0 (en) 1992-12-02 1992-12-02 Process
PCT/EP1993/003376 WO1994012460A1 (en) 1992-12-02 1993-11-30 Process for preparing substantially pure enantiomers of phenylpropionic acids
EP9303376 1993-11-30

Publications (3)

Publication Number Publication Date
FI952677A0 FI952677A0 (sv) 1995-06-01
FI952677A true FI952677A (sv) 1995-06-01
FI110776B FI110776B (sv) 2003-03-31

Family

ID=26302084

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952677A FI110776B (sv) 1992-12-02 1995-06-01 Förfarande för framställning av väsentligen rena enantiomerer av substituerade fenylpropionsyror

Country Status (12)

Country Link
US (1) US5599969A (sv)
EP (1) EP0672030B1 (sv)
JP (1) JPH08504193A (sv)
KR (1) KR100280766B1 (sv)
AT (1) ATE151740T1 (sv)
AU (1) AU672269B2 (sv)
CA (1) CA2150355C (sv)
DE (1) DE69309958T2 (sv)
ES (1) ES2100037T3 (sv)
FI (1) FI110776B (sv)
RU (1) RU2133733C1 (sv)
WO (1) WO1994012460A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380867A (en) * 1992-12-02 1995-01-10 Hoechst Celanese Corporation Selective precipitation of α-aryl carboxylic acid salts
IN189741B (sv) * 1998-11-09 2003-04-19 Council Scient Ind Res
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
JP2002069030A (ja) * 2000-08-30 2002-03-08 Kyowa Hakko Kogyo Co Ltd ナトリウム２−｛４−［（２−オキソシクロペンチル）メチル］フェニル｝プロピオネート２水和物の製造法
JP2006335639A (ja) * 2003-01-23 2006-12-14 Nagase & Co Ltd 光学活性なフルルビプロフェンの製造方法
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005108683A1 (en) * 2004-04-29 2005-11-17 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
AU2005302554A1 (en) * 2004-10-28 2006-05-11 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
BRPI0613611A2 (pt) * 2005-07-22 2011-01-18 Myriad Genetics Inc formulações de alta concentração de fármaco e formas de dosagens
US7754679B2 (en) * 2005-11-16 2010-07-13 Idexx Laboratories, Inc. Pharmaceutical compositions for the administration of aptamers
US8114440B2 (en) * 2005-11-16 2012-02-14 Idexx Laboratories Inc. Pharmaceutical compositions for the administration of aptamers
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
CA2677125C (en) * 2007-02-01 2018-07-10 Myriad Genetics, Inc. Drug substance preparations, pharmaceutical compositions and dosage forms
US8828960B2 (en) * 2007-07-17 2014-09-09 Idexx Laboratories, Inc. Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
GB0811851D0 (en) * 2008-06-30 2008-07-30 Aesica Pharmaceuticals Ltd Process
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
GB201405456D0 (en) * 2014-03-26 2014-05-07 Aesica Pharmaceuticals Ltd Process for the manufacture of S-(+)-Flurbiprofen
CN115286501A (zh) * 2022-08-10 2022-11-04 浙江新和成股份有限公司 一种布洛芬结晶母液的综合利用方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
IT1059677B (it) * 1974-03-22 1982-06-21 Neopharmed Spa Sale di lisina ad azione terapeutica
JPS55136245A (en) * 1979-04-09 1980-10-23 Sumitomo Chem Co Ltd Optical resolution of alpha-isopropyl-p-chlorophenyl-acetic acid
DE3824353A1 (de) * 1988-07-19 1990-01-25 Paz Arzneimittelentwicklung Verfahren zur trennung von gemischen enantiomerer arylpropionsaeuren
KR920700613A (ko) * 1989-05-16 1992-08-10 지구르트 퓌터 약제제
DK0424028T3 (da) * 1989-10-17 1996-01-29 Merck & Co Inc S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
US5200558A (en) * 1989-10-17 1993-04-06 Merck & Co., Inc. S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset-hastened enhanced analgesics
US4994604A (en) * 1990-01-10 1991-02-19 Merck & Co., Inc. Formation and resolution of ibuprofen lysinate
US5015764A (en) * 1990-06-18 1991-05-14 Ethyl Corporation Preparation of optically active aliphatic carboxylic acids
DE4028906A1 (de) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung Arzneimittel sowie deren herstellung und deren verwendung bei der bekaempfung von schmerzen und/oder entzuendungen und/oder fieber an tieren und menschen
HUT59656A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing s/+/-phenyl-alkanoic acids and alpha-amino-acids containing complexes and pharmaceutical compositions containing them as active components
HUT59692A (en) * 1990-11-15 1992-06-29 Puetter Medice Chem Pharm Process for producing complexes containing s/+/-phenyl-alkanoic acids and aminosugars
DK0505180T3 (da) * 1991-03-22 1997-03-24 Merck & Co Inc Farmaceutisk præparat med højt indhold af ibuprofenlysinat
ES2148175T3 (es) * 1991-05-13 2000-10-16 Boots Co Plc Composicion farmaceutica que contiene una sal de ibuprofeno.
FR2687673B1 (fr) * 1992-01-13 1995-07-07 Jung Jean Sels amines d'acides arylcarboxyliques, sterilisables, solubles dans l'eau, utilises en ophtalmologie et/ou dans la sphere otorhinolaryngologique.
US5302751A (en) * 1992-01-21 1994-04-12 Ethyl Corporation Profen resolution
US5288507A (en) * 1992-07-29 1994-02-22 Merck & Co., Inc. Ibuprofen antacid combinations
WO1994003209A1 (en) * 1992-07-29 1994-02-17 Merck & Co., Inc. Dexibuprofen/antacid/simethicone combinations
AU5132893A (en) * 1992-09-29 1994-04-26 Mcneil-Ppc, Inc. Ibuprofen-caffeine combinations
US5248813A (en) * 1992-10-14 1993-09-28 Ethyl Corporation Enantiomeric resolution
US5260482A (en) * 1992-10-14 1993-11-09 Ethyl Corporation Enantiomeric resolution
US5278337A (en) * 1992-10-14 1994-01-11 Ethyl Corporation Enantiomeric resolution of aryl-substituted aliphatic carboxylic acids
US5380867A (en) * 1992-12-02 1995-01-10 Hoechst Celanese Corporation Selective precipitation of α-aryl carboxylic acid salts

Also Published As

Publication number Publication date
ATE151740T1 (de) 1997-05-15
DE69309958D1 (de) 1997-05-22
CA2150355A1 (en) 1994-06-09
RU2133733C1 (ru) 1999-07-27
WO1994012460A1 (en) 1994-06-09
FI110776B (sv) 2003-03-31
US5599969A (en) 1997-02-04
RU95113445A (ru) 1997-06-10
FI952677A0 (sv) 1995-06-01
EP0672030A1 (en) 1995-09-20
KR100280766B1 (ko) 2001-02-01
ES2100037T3 (es) 1997-06-01
CA2150355C (en) 2008-03-11
EP0672030B1 (en) 1997-04-16
KR950704226A (ko) 1995-11-17
DE69309958T2 (de) 1997-07-24
AU672269B2 (en) 1996-09-26
AU5650494A (en) 1994-06-22
JPH08504193A (ja) 1996-05-07

Similar Documents

Publication Publication Date Title
FI952677A (sv) Förfarande för framställning av väsentligen rena enantiomerer av fenylpropionsyra
AU7137591A (en) New derivatives having naphthalene structure, process for preparing these and pharmaceutical compositions containing them
ATE347607T1 (de) Verfahren zur herstellung von decosahexaensäure und decosapentsäure
TNSN88012A1 (fr) Procede de preparation de l&#39;enantiomere dextrogyre de l&#39;alpha (tetrahydro-4,5,6,7 thieno (3,2-c) pyridyl - 5) (chloro -2 phenyl) acetate de methyle
CZ114995A3 (en) Tromethamine salt (+)-(s)-2-(3-benzoylphenyl)propionic acid, process of its preparation and a pharmaceutical composition containing thereof
DK0828702T3 (da) Fremgangsmåde til opløsning af chirale syrer med 1-aminoindan-2-oler
Büch et al. Stereochemical dependence of pharmacological activity in a series of optically active N-methylated barbiturates
ATE224896T1 (de) Verfahren zur herstellung von enantiomerisch reinen imidazol-verbindungen
RU94046047A (ru) Производные аминоуксусной кислоты в виде рацемата или d- и l-энантиомеров и их фармацевтически приемлемые соли, способ получения d- и l-энантиомеров производных аминоуксусной кислоты или их фармацевтически приемлемых солей и промежуточные d- и l-энантиомеры аминоуксусной кислоты в виде цинхонидиновой соли
TW343975B (en) New phospholipid derivatives of phosphonocarboxylic acids, the production thereof as well as their use as antiviral pharmaceutical agents
ES2145260T3 (es) Mejoras introducidas en sintesis quirales.
FI103807B1 (sv) Förfarande för framställning av huvudsakligen den ena enantiomeren av kiral 2-(3-benzoylfenyl)propionsyra
ES2127278T3 (es) Preparados de acidos 2-aril-propionicos y procedimiento para su produccion.
ATE127465T1 (de) Isoindolinon-derivat, seine herstellung und dieses enthaltende pharmazeutische zusammen setzungen.
ZA888663B (en) Substituted derivatives of 20,21-dinoreburanamenine,their preparation process and the new intermediates thus obtained,their use as medicaments and the pharmaceutical compositions containing them
CA2112981A1 (fr) Procede de preparation des isomeres optiques d&#39;un derive de l&#39;amino-2 naphtyridine
NO930546L (no) Fremgangsmaate for omdanning av 2(3-benzoylfenyl)propionsyre til en s(+)isomer
ATE193280T1 (de) Verfahren zur herstellung von beta-amino-alpha- hydroxycarbonsäuren und deren derivaten
IT1254463B (it) Processo per la preparazione di (r) e (s)-1,2-isopropilidenglicerolo
AU2395401A (en) Stereospecific hydrolysis of optically active esters
CA2112982A1 (fr) Procede de preparation des isomeres optiques d&#39;un derive de l&#39;amino-2 naphtyridine
DE60222418D1 (de) Hydroxybuttersäureester von acetylsalizylsäure, deren herstellung und anwendung sowie diese enthaltenden arzneimittel
DK0824512T3 (da) Syntese af optisk aktivt aminoindanol
HUP9601362A2 (hu) Eljárás optikailag aktív vegyületek előállítására
DE50009160D1 (de) Verfahren zur herstellung von optisch aktiven 3,3,3- trifluormethyl- 2- alkylpropionsäurederivaten

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AESICA PHARMACEUTICALS LTD.

Free format text: AESICA PHARMACEUTICALS LTD.